Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001723128-19-000120
Filing Date
2019-08-28
Accepted
2019-08-28 16:53:40
Documents
1
Period of Report
2019-08-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156702560470079.html 4  
1 FORM 4 wf-form4_156702560470079.xml 4 3656
  Complete submission text file 0001723128-19-000120.txt   4974
Mailing Address 25 BLACK HAWK IRVINE CA 92603
Business Address
Nark Ted C (Reporting) CIK: 0001316851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 191062548

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations